Sacvaly 24/26Mg 60 Film Coated Tablet

Sacvaly 26/24 mg Tablets (60 Tablets)

Prescription required: Sacvaly 26/24 mg Tablets (60 Tablets) is a prescription-only cardiovascular medication used in the management of chronic heart failure.

Drug Overview

Sacvaly 26/24 mg Tablets (60 Tablets) is a combination medicine designed to improve heart function in patients with chronic heart failure. It contains sacubitril and valsartan, a dual-acting therapy that reduces strain on the heart and enhances blood circulation. Sacvaly 26/24 mg Tablets is commonly prescribed as part of long-term heart failure management to improve symptoms and reduce the risk of hospitalization.

Active Ingredient and Composition

This medication contains a combination of:

• Sacubitril – a neprilysin inhibitor that increases beneficial peptides
• Valsartan – an angiotensin II receptor blocker (ARB) that relaxes blood vessels

Together, these components form a dual mechanism that supports cardiovascular function.

Drug Class

Sacvaly belongs to the class of angiotensin receptor neprilysin inhibitors (ARNI), used in the treatment of heart failure with reduced ejection fraction.

Uses of Sacvaly 26/24 mg Tablets

Sacvaly 26/24 mg Tablets (60 Tablets) is used for:

• Management of chronic heart failure in adults
• Improving cardiac efficiency and pumping function
• Reducing symptoms such as shortness of breath and fatigue
• Lowering the risk of hospitalization due to worsening heart failure

How Sacvaly 26/24 mg Tablets Works

Sacvaly 26/24 mg Tablets works through a dual-action mechanism. Sacubitril enhances levels of natriuretic peptides, which help reduce fluid overload and decrease cardiac stress. Valsartan blocks angiotensin II receptors, leading to vasodilation and lower blood pressure. This combined effect improves heart function and reduces workload on the heart.

Dosage and Administration

The dosage of Sacvaly 26/24 mg Tablets should be determined by a healthcare provider based on the patient’s condition and tolerance.

• Typically taken twice daily
• Can be taken with or without food
• Swallow tablets whole with water
• Adherence to dosing schedule is essential for optimal results

Possible Side Effects

Common side effects may include:

• Low blood pressure (hypotension)
• Dizziness or fatigue
• Elevated potassium levels (hyperkalemia)
• Impaired kidney function in some patients

Contraindications

• Known hypersensitivity to sacubitril or valsartan
• Concomitant use with certain ACE inhibitors
• History of angioedema related to similar medications

Drug Interactions

Sacvaly 26/24 mg Tablets may interact with:

• Other blood pressure medications
• ACE inhibitors (should not be used together)
• Potassium supplements or potassium-sparing diuretics

Always inform your healthcare provider about all medications being taken.

Warnings and Precautions

• Use cautiously in patients with kidney or liver disease
• Monitor blood pressure regularly
• Assess potassium levels during treatment
• Avoid use in patients with severe hypotension

Use During Pregnancy and Breastfeeding

This medication is not recommended during pregnancy due to potential harm to the fetus. Breastfeeding use should be discussed with a healthcare provider.

Use for Children

The safety and efficacy of Sacvaly in children have not been fully established. Use should be based on specialist evaluation.

Drug Alternatives

Other treatment options for heart failure may include ACE inhibitors, ARBs, beta-blockers, or other ARNI medications depending on the patient’s condition and response.

Comparison With Similar Drugs

Compared with traditional ACE inhibitors or ARBs alone, Sacvaly provides a dual mechanism through neprilysin inhibition and angiotensin receptor blockade. This combination has been shown to improve outcomes in patients with chronic heart failure when used appropriately.

Safe Usage Tips

• Take medication exactly as prescribed
• Do not skip doses
• Monitor blood pressure and kidney function regularly
• Avoid sudden discontinuation without medical advice
• Follow dietary recommendations for heart failure

Conclusion

Sacvaly 26/24 mg Tablets (60 Tablets) is an effective treatment option for chronic heart failure, combining sacubitril and valsartan to improve cardiac function and reduce disease burden. When used under medical supervision, Sacvaly 26/24 mg Tablets can significantly enhance quality of life and long-term outcomes for patients.